Fortrea Holdings Inc. reported $2.68B of revenue over the trailing twelve months, −2.1% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.68B (to Q2 2026). Net income: −$85M, trailing twelve months to Q2 2026. Free cash flow: $196M, trailing twelve months to Q2 2026. Operating margin: −0.41%, trailing twelve months to Q2 2026.

FTREFortrea Holdings Inc.

Healthcare

$20.85+106% 1Y

$20.85

$8.4052 weeks$21.12

FTRE as reported

Fortrea Holdings Inc. reported $2.68B of revenue over the trailing twelve months, −2.1% on the year before. 10 reported series are charted on this page, each one as filed.

$2.68B

Revenue, trailing twelve months · to Q2 2026 · −2.1% against the twelve months before

Net income: −$85M
Net income · −92% year on year · trailing twelve months to Q2 2026
Free cash flow: $196M
Free cash flow · −279% year on year · trailing twelve months to Q2 2026
Operating margin: −0.41%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for FTRE, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.68B	−2.1%	Q2 2026
Net income	−$85M	−92%	Q2 2026
EPS	−$0.84	−93%	Q2 2026
Gross margin	19%	n/a	Q2 2026
Operating margin	−0.41%	n/a	Q2 2026
Net margin	−3.2%	n/a	Q2 2026
ROE	−113%	n/a	Q2 2026
ROA	−23%	n/a	Q2 2026
ROIC	−28%	n/a	Q2 2026
Free cash flow	$196M	−279%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.